Jennifer A Chan Selected Research

Jennifer A Chan Research Topics

Disease

58	Neoplasms (Cancer) 11/2022 - 11/2003
18	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 05/2007
13	Medulloblastoma 01/2022 - 11/2003
11	Brain Neoplasms (Brain Tumor) 06/2022 - 11/2003
10	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 12/2006
10	Glioma (Gliomas) 10/2020 - 11/2006
9	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 11/2003
7	Carcinogenesis 01/2022 - 12/2006
7	Carcinoid Tumor (Carcinoid) 07/2017 - 06/2011
6	Colonic Neoplasms (Colon Cancer) 01/2015 - 06/2008
4	Primitive Neuroectodermal Tumors (PNET) 01/2022 - 03/2014
4	Neutropenia 01/2019 - 01/2010
4	Astrocytoma (Pilocytic Astrocytoma) 05/2013 - 12/2004
3	Hypertension (High Blood Pressure) 01/2019 - 01/2010
3	Disease Progression 01/2019 - 02/2016
3	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2007
3	Oligodendroglioma 09/2014 - 01/2012
3	Tuberous Sclerosis (Bourneville's Disease) 11/2011 - 12/2004
2	Fatigue 10/2020 - 05/2017
2	Diarrhea 10/2020 - 01/2012
2	Adenocarcinoma 01/2019 - 06/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 11/2008
2	Ependymoma 01/2016 - 11/2014
2	Lymphopenia (Lymphocytopenia) 06/2014 - 08/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2014 - 01/2009
2	Thrombocytopenia (Thrombopenia) 08/2012 - 01/2009
2	Microsatellite Instability 03/2010 - 06/2008
1	Pheochromocytoma 01/2022
1	Paraganglioma (Paragangliomas) 01/2022
1	Body Weight Changes 11/2020
1	Genomic Instability 12/2019
1	Hypersensitivity (Allergy) 01/2019
1	Cerebral Hemorrhage 01/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2003
8	Everolimus FDA Link 01/2022 - 01/2009
6	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 05/2009
6	ParaffinIBA 01/2022 - 11/2008
6	Formaldehyde (Formol)FDA Link 01/2022 - 11/2008
6	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2010
6	MicroRNAs (MicroRNA)IBA 02/2016 - 07/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2007
4	NucleotidesIBA 11/2021 - 10/2019
4	RNA (Ribonucleic Acid)IBA 01/2020 - 07/2009
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2012
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 05/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 07/2009
3	Pharmaceutical PreparationsIBA 10/2020 - 02/2014
3	Octreotide (Sandostatin)FDA LinkGeneric 05/2017 - 06/2011
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2014 - 09/2012
3	trans-sodium crocetinate (crocetin)IBA 11/2011 - 12/2004
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2018
2	AZD 6244IBA 01/2022 - 01/2018
2	ChromatinIBA 10/2021 - 01/2019
2	Cholecalciferol (Vitamin D3)FDA Link 11/2020 - 01/2019
2	Angiogenesis InhibitorsIBA 01/2019 - 08/2011
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 10/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 01/2010
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2018 - 11/2016
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2018 - 02/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 04/2002
2	pasireotideIBA 01/2017 - 10/2012
2	Biological ProductsIBA 08/2014 - 12/2013
2	Alanine Transaminase (SGPT)IBA 06/2014 - 01/2010
2	Cetuximab (Erbitux)FDA Link 02/2014 - 01/2012
2	Monoclonal AntibodiesIBA 02/2014 - 08/2012
2	ErbB Receptors (EGF Receptor)IBA 02/2014 - 02/2008
2	TOR Serine-Threonine KinasesIBA 09/2013 - 05/2007
2	Sirolimus (Rapamycin)FDA Link 09/2013 - 11/2011
2	Proto-Oncogene Proteins B-rafIBA 05/2013 - 11/2011
2	MTOR InhibitorsIBA 06/2011 - 01/2009
2	Gemcitabine FDA Link 01/2010 - 01/2009
2	beta CateninIBA 09/2009 - 09/2008
2	Streptozocin (Streptozotocin)FDA Link 05/2009 - 05/2007
2	plerixafor FDA Link 11/2006 - 11/2003
1	diethylstilbestrol monophosphate (PDES)IBA 11/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 11/2020
1	Vitamin D FDA LinkGeneric 11/2020
1	CytokinesIBA 10/2020
1	Interleukin-33IBA 10/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2020
1	STA 9090IBA 10/2020
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	U1 small nuclear RNAIBA 10/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	afliberceptIBA 01/2019
1	Leucovorin (Folinic Acid)FDA Link 01/2019
1	hydroxide ionIBA 01/2019
1	25-hydroxyvitamin DIBA 01/2019
1	Antimitotic AgentsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 10/2018
1	Peptide Receptors (Peptide Receptor)IBA 09/2018
1	lutetium Lu 177 dotatateIBA 09/2018
1	Radioisotopes (Radionuclides)IBA 09/2018

Therapy/Procedure

21	Therapeutics 01/2022 - 11/2006
8	Drug Therapy (Chemotherapy) 01/2022 - 11/2006
5	Adjuvant Chemotherapy 01/2015 - 06/2008
2	Radiotherapy 01/2016 - 11/2014
1	Cranial Irradiation 06/2022